Login Register Cart 0
Generic placeholder image

Current Traditional Medicine

Editor-in-Chief

ISSN (Print): 2215-0838
ISSN (Online): 2215-0846

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Mini-Review Article

Therapeutic Potential of Indian Medicinal Herbs and Current Therapeutic Approach used to Mitigate the Symptoms of Chronic Fatigue Syndrome: A Review

Author(s): Nisha Singh, Rahul Kumar Sharma*, Ajay Singh Kushwah and Manish Kumar

Volume 10, Issue 4, 2024

Published on: 31 July, 2023

Article ID: e260623218250 Pages: 14

DOI: 10.2174/2215083810666230626115456

Price: $65

conference banner
Abstract

Chronic fatigue syndrome (CFS) is a complex condition marked by severe exhaustion that lasts at least 6 months. The global prevalence of CFS ranging between 0.4% and 2.5% is growing. Women are affected by CFS more often than men. It is considered a common condition in developed countries. There is no approved treatment for CFS but symptoms can be managed and controlled persistent exhaustion causes significant impairment in daily routine activities. Lowered ATP synthesis, mitochondrial impairment, decreased oxidative phosphorylation, disruption of the hypothalamic–pituitary–adrenal (HPA) axis, and an imbalance of brain neurotransmitters play a major role in the pathophysiology of CFS. The purpose of the present study is to figure out the several plants that are used as a source of medication in chronic fatigue syndrome (CFS) and its current therapeutic approach. The Indian medicinal herbs described in this article are very efficacious in the management of chronic fatigue syndrome symptoms due to the presence of phytochemicals. This review article also covers the current therapeutic approach for chronic fatigue syndrome in a concise form that comprises CBT (Cognitive based therapy), GET (Graded exercise therapy), usage of immunoglobins, psychodynamic counseling, and yoga therapy that includes isometric yoga and yoga nidra are very beneficial in alleviating the symptoms of chronic fatigue syndrome. Antidepressants, immunomodulatory agents, and corticosteroids come under conventional medication for CFS. This article explores different Indian medicinal herbs, their pharmacological properties, and their potential role and current treatments for reducing the severity of symptoms of chronic fatigue syndrom

Keywords: CFS (Chronic Fatigue Syndrome), Indian medicinal herbs, current therapeutic approach, corticosteroids, CBT, HPA.

[1]
Wyller VB. The chronic fatigue syndrome? an update. Acta Neurol Scand 2007; 115(s187): 7-14.
[http://dx.doi.org/10.1111/j.1600-0404.2007.00840.x] [PMID: 17419822]
[2]
Moss-Morris R, Deary V, Castell B. Chronic fatigue syndrome. Handb Clin Neurol 2013; 110: 303-14.
[http://dx.doi.org/10.1016/B978-0-444-52901-5.00025-3] [PMID: 23312650]
[3]
Fukuda K, Straus SE, Hickie I, Sharpe MC, Dobbins JG, Komaroff A. The chronic fatigue syndrome: a comprehensive approach to its definition and study. Ann Intern Med 1994; 121(12): 953-9.
[http://dx.doi.org/10.7326/0003-4819-121-12-199412150-00009] [PMID: 7978722]
[4]
Jorgensen R. Chronic fatigue: an evolutionary concept analysis. J Adv Nurs 2008; 63(2): 199-207.
[http://dx.doi.org/10.1111/j.1365-2648.2008.04649.x] [PMID: 18638162]
[5]
Whitehead LC. Quest, chaos and restitution: Living with chronic fatigue syndrome/myalgic encephalomyelitis. Soc Sci Med 2006; 62(9): 2236-45.
[http://dx.doi.org/10.1016/j.socscimed.2005.09.008] [PMID: 16236413]
[6]
Butler S, Chalder T, Ron M, Wessely S. Cognitive behaviour therapy in chronic fatigue syndrome. J Neurol Neurosurg Psychiatry 1991; 54(2): 153-8.
[http://dx.doi.org/10.1136/jnnp.54.2.153] [PMID: 2019842]
[7]
Skapinakis P, Lewis G, Mavreas V. Cross-cultural differences in the epidemiology of unexplained fatigue syndromes in primary care. Br J Psychiatry 2003; 182(3): 205-9.
[http://dx.doi.org/10.1192/bjp.182.3.205] [PMID: 12611782]
[8]
Prins JB, Bleijenberg G, van der Meer JWM. Chronic fatigue syndrome – Authors’ reply. Lancet 2006; 367(9522): 1575.
[http://dx.doi.org/10.1016/S0140-6736(06)68689-3]
[9]
Reyes M, Nisenbaum R, Hoaglin DC, et al. Prevalence and incidence of chronic fatigue syndrome in Wichita, Kansas. Arch Intern Med 2003; 163(13): 1530-6.
[http://dx.doi.org/10.1001/archinte.163.13.1530] [PMID: 12860574]
[10]
Kendell P. Chronic fatigue, viruses, and depression. Lancet 1991; 337(8734): 160-2.
[http://dx.doi.org/10.1016/0140-6736(91)90814-6] [PMID: 1670800]
[11]
Speight N. Myalgic encephalomyelitis/chronic fatigue syndrome: Review of history, clinical features, and controversies. Saudi J Med Med Sci 2013; 1(1): 11.
[http://dx.doi.org/10.4103/1658-631X.112905]
[12]
Chen R, Liang FX, Moriya J, et al. Chronic fatigue syndrome and the central nervous system. J Int Med Res 2008; 36(5): 867-74.
[http://dx.doi.org/10.1177/147323000803600501] [PMID: 18831878]
[13]
Ferrero K, Silver M, Cocchetto A, Masliah E, Langford D. CNS findings in chronic fatigue syndrome and a neuropathological case report. J Investig Med 2017; 65(6): 974-83.
[http://dx.doi.org/10.1136/jim-2016-000390] [PMID: 28386034]
[14]
Katafuchi T, Kondo T, Take S, Yoshimura M. Brain cytokines and the 5-HT system during poly I:C-induced fatigue. Ann N Y Acad Sci 2006; 1088(1): 230-7.
[http://dx.doi.org/10.1196/annals.1366.020] [PMID: 17192569]
[15]
Yamamoto S, Ouchi Y, Nakatsuka D, et al. Reduction of [11C](+)3-MPB binding in brain of chronic fatigue syndrome with serum autoantibody against muscarinic cholinergic receptor. PLoS One 2012; 7(12): e51515.
[http://dx.doi.org/10.1371/journal.pone.0051515] [PMID: 23240035]
[16]
Kennedy G, Spence VA, McLaren M, Hill A, Underwood C, Belch JJF. Oxidative stress levels are raised in chronic fatigue syndrome and are associated with clinical symptoms. Free Radic Biol Med 2005; 39(5): 584-9.
[http://dx.doi.org/10.1016/j.freeradbiomed.2005.04.020] [PMID: 16085177]
[17]
Morris G, Anderson G, Galecki P, Berk M, Maes M. A narrative review on the similarities and dissimilarities between myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and sickness behavior. BMC Med 2013; 11(1): 64.
[http://dx.doi.org/10.1186/1741-7015-11-64]
[18]
Nijs J, Nees A, Paul L, et al. Altered immune response to exercise in patients with chronic fatigue syndrome/myalgic encephalomyelitis: A systematic literature review. Exerc Immunol Rev 2014; 20: 94-116.
[PMID: 24974723]
[19]
Papadopoulos AS, Cleare AJ. Hypothalamic–pituitary–adrenal axis dysfunction in chronic fatigue syndrome. Nat Rev Endocrinol 2012; 8(1): 22-32.
[http://dx.doi.org/10.1038/nrendo.2011.153]
[20]
Tomas C, Newton J. A review of hypothalamic- Pituitary-adrenal axis function in chronic fatigue syndrome. Int Sch Res Notices 2013.
[21]
Chia JKS. The role of enterovirus in chronic fatigue syndrome. J Clin Pathol 2005; 58(11): 1126-32.
[http://dx.doi.org/10.1136/jcp.2004.020255] [PMID: 16254097]
[22]
Montoya JG, Kogelnik AM, Bhangoo M, et al. Randomized clinical trial to evaluate the efficacy and safety of valganciclovir in a subset of patients with chronic fatigue syndrome. J Med Virol 2013; 85(12): 2101-9.
[http://dx.doi.org/10.1002/jmv.23713] [PMID: 23959519]
[23]
Logan AC, Wong C. Chronic fatigue syndrome: oxidative stress and dietary modifications. Altern Med Rev 2001; 6(5): 450-9.
[PMID: 11703165]
[24]
Vecchiet J, Cipollone F, Falasca K, et al. Relationship between musculoskeletal symptoms and blood markers of oxidative stress in patients with chronic fatigue syndrome. Neurosci Lett 2003; 335(3): 151-4.
[http://dx.doi.org/10.1016/S0304-3940(02)01058-3] [PMID: 12531455]
[25]
Wirth K, Scheibenbogen C. A Unifying Hypothesis of the Pathophysiology of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): Recognitions from the finding of autoantibodies against ß2-adrenergic receptors. Autoimmun Rev 2020; 19(6): 102527.
[http://dx.doi.org/10.1016/j.autrev.2020.102527] [PMID: 32247028]
[26]
Werbach MR. Nutritional strategies for treating chronic fatigue syndrome. Altern Med Rev 2000; 5(2): 93-108.
[PMID: 10767667]
[27]
Rimes KA, Chalder T. Treatments for chronic fatigue syndrome. Occup Med (Lond) 2005; 55(1): 32-9.
[http://dx.doi.org/10.1093/occmed/kqi015] [PMID: 15699088]
[28]
Castro-Marrero J, Sáez-Francàs N, Santillo D, Alegre J. Treatment and management of chronic fatigue syndrome/myalgic encephalomyelitis: All roads lead to Rome. Br J Pharmacol 2017; 174(5): 345-69.
[http://dx.doi.org/10.1111/bph.13702] [PMID: 28052319]
[29]
Theoharides TC, Asadi S, Weng Z, Zhang B. Serotonin-selective reuptake inhibitors and nonsteroidal anti-inflammatory drugs--important considerations of adverse interactions especially for the treatment of myalgic encephalomyelitis/chronic fatigue syndrome. J Clin Psychopharmacol 2011; 31(4): 403-5.
[http://dx.doi.org/10.1097/JCP.0b013e318225848c] [PMID: 21694612]
[30]
Attree EA, Arroll MA, Dancey CP, Griffith C, Bansal AS. Psychosocial factors involved in memory and cognitive failures in people with myalgic encephalomyelitis/chronic fatigue syndrome. Psychol Res Behav Manag 2014; 7: 67-76.
[PMID: 24596470]
[31]
Jackson JL, O’Malley PG, Kroenke K. Antidepressants and cognitive-behavioral therapy for symptom syndromes. CNS Spectr 2006; 11(3): 212-22.
[http://dx.doi.org/10.1017/S1092852900014383] [PMID: 16575378]
[32]
Pae CU, Marks DM, Patkar AA, Masand PS, Luyten P, Serretti A. Pharmacological treatment of chronic fatigue syndrome: focusing on the role of antidepressants. Expert Opin Pharmacother 2009; 10(10): 1561-70.
[http://dx.doi.org/10.1517/14656560902988510] [PMID: 19514866]
[33]
Sanders P, Korf J. Neuroaetiology of chronic fatigue syndrome: An overview. World J Biol Psychiatry 2008; 9(3): 165-71.
[http://dx.doi.org/10.1080/15622970701310971] [PMID: 17853290]
[34]
Jason LA, Corradi K, Torres-Harding S, Taylor RR, King C. Chronic fatigue syndrome: the need for subtypes. Neuropsychol Rev 2005; 15(1): 29-58.
[http://dx.doi.org/10.1007/s11065-005-3588-2] [PMID: 15929497]
[35]
Whiting P, Bagnall AM, Sowden AJ, Cornell JE, Mulrow CD, Ramírez G. Interventions for the treatment and management of chronic fatigue syndrome: A systematic review. JAMA 2001; 286(11): 1360-8.
[http://dx.doi.org/10.1001/jama.286.11.1360] [PMID: 11560542]
[36]
Alraek T, Lee MS, Choi TY, Cao H, Liu J. Complementary and alternative medicine for patients with chronic fatigue syndrome: A systematic review. BMC Complement Altern Med 2011; 11(1): 87.
[http://dx.doi.org/10.1186/1472-6882-11-87] [PMID: 21982120]
[37]
Butler A, Chapman J, Forman E, Beck A. The empirical status of cognitive-behavioral therapy: A review of meta-analyses. Clin Psychol Rev 2006; 26(1): 17-31.
[http://dx.doi.org/10.1016/j.cpr.2005.07.003] [PMID: 16199119]
[38]
Nijhof SL, Bleijenberg G, Uiterwaal CSPM, Kimpen JLL, van de Putte EM. Effectiveness of internet-based cognitive behavioural treatment for adolescents with chronic fatigue syndrome (FITNET): a randomised controlled trial. Lancet 2012; 379(9824): 1412-8.
[http://dx.doi.org/10.1016/S0140-6736(12)60025-7] [PMID: 22385683]
[39]
Chambers D, Bagnall AM, Hempel S, Forbes C. Interventions for the treatment, management and rehabilitation of patients with chronic fatigue syndrome/myalgic encephalomyelitis: an updated systematic review. J R Soc Med 2006; 99(10): 506-20.
[PMID: 17021301]
[40]
Larun L, Brurberg KG, Odgaard-Jensen J, Price JR. Exercise therapy for chronic fatigue syndrome. Cochrane Database Syst Rev 2019; 10(10): CD003200.
[PMID: 31577366]
[41]
Moss-Morris R, Sharon C, Tobin R, Baldi JC. A randomized controlled graded exercise trial for chronic fatigue syndrome: outcomes and mechanisms of change. J Health Psychol 2005; 10(2): 245-59.
[http://dx.doi.org/10.1177/1359105305049774] [PMID: 15723894]
[42]
Windgassen S, Goldsmith K, Moss-Morris R, Chalder T. Establishing how psychological therapies work: the importance of mediation analysis. J Ment Health 2016; 25(2): 93-9.
[http://dx.doi.org/10.3109/09638237.2015.1124400] [PMID: 26732531]
[43]
Ridsdale L, Godfrey E, Chalder T, et al. Chronic fatigue in general practice: is counselling as good as cognitive behaviour therapy? A UK randomised trial. Br J Gen Pract 2001; 51(462): 19-24.
[PMID: 11271868]
[44]
Bentler SE, Hartz AJ, Kuhn EM. Prospective observational study of treatments for unexplained chronic fatigue. J Clin Psychiatry 2005; 66(5): 625-32.
[http://dx.doi.org/10.4088/JCP.v66n0513] [PMID: 15889950]
[45]
Yoshihara K, Hiramoto T, Oka T, Kubo C, Sudo N. Effect of 12 weeks of yoga training on the somatization, psychological symptoms, and stress-related biomarkers of healthy women. Biopsychosoc Med 2014; 8(1): 1-9.
[http://dx.doi.org/10.1186/1751-0759-8-1] [PMID: 24383884]
[46]
Oka T, Tanahashi T, Chijiwa T, Lkhagvasuren B, Sudo N, Oka K. Isometric yoga improves the fatigue and pain of patients with chronic fatigue syndrome who are resistant to conventional therapy: a randomized, controlled trial. Biopsychosoc Med 2014; 8(1): 27.
[http://dx.doi.org/10.1186/s13030-014-0027-8] [PMID: 25525457]
[47]
Hoad A, Spickett G, Elliott J, Newton J. Postural orthostatic tachycardia syndrome is an under-recognized condition in chronic fatigue syndrome. QJM 2008; 101(12): 961-5.
[http://dx.doi.org/10.1093/qjmed/hcn123] [PMID: 18805903]
[48]
Kamei T, Toriumi Y, Kimura H, Kumano H, Ohno S, Kimura K. Decrease in serum cortisol during yoga exercise is correlated with alpha wave activation. Percept Mot Skills 2000; 90(3): 1027-32.
[http://dx.doi.org/10.2466/pms.2000.90.3.1027] [PMID: 10883793]
[49]
Pullen PR, Nagamia SH, Mehta PK, et al. Effects of yoga on inflammation and exercise capacity in patients with chronic heart failure. J Card Fail 2008; 14(5): 407-13.
[http://dx.doi.org/10.1016/j.cardfail.2007.12.007] [PMID: 18514933]
[50]
Kiecolt-Glaser JK, Christian L, Preston H, et al. Stress, inflammation, and yoga practice. Psychosom Med 2010; 72(2): 113-21.
[http://dx.doi.org/10.1097/PSY.0b013e3181cb9377] [PMID: 20064902]
[51]
Barrows KA, Jacobs BP. Mind-body medicine: An introduction and review of the literature. Med Clin North Am 2002; 86(1): 11-31.
[http://dx.doi.org/10.1016/S0025-7125(03)00069-5] [PMID: 11795084]
[52]
Kiecolt-Glaser JK, McGuire L, Robles TF, Glaser R. Emotions, morbidity, and mortality: new perspectives from psychoneuroimmunology. Annu Rev Psychol 2002; 53(1): 83-107.
[http://dx.doi.org/10.1146/annurev.psych.53.100901.135217] [PMID: 11752480]
[53]
Yadav R, Mehta M, Mahapatra SC, Magan D, Mehta N. A short-term, comprehensive, yoga-based lifestyle intervention is efficacious in reducing anxiety, improving subjective well-being and personality. Int J Yoga 2012; 5(2): 134-9.
[http://dx.doi.org/10.4103/0973-6131.98235] [PMID: 22869998]
[54]
Telles S, Gaur V, Balkrishna A. Effect of a yoga practice session and a yoga theory session on state anxiety. Percept Mot Skills 2009; 109(3): 924-30.
[http://dx.doi.org/10.2466/pms.109.3.924-930] [PMID: 20178291]
[55]
Gupta N, Khera S, Vempati RP, Sharma R, Bijlani RL. Effect of yoga based lifestyle intervention on state and trait anxiety. Indian J Physiol Pharmacol 2006; 50(1): 41-7.
[PMID: 16850902]
[56]
Stringer EA, Baker KS, Carroll IR, et al. Daily cytokine fluctuations, driven by leptin, are associated with fatigue severity in chronic fatigue syndrome: Evidence of inflammatory pathology. J Transl Med 2013; 11(1): 93.
[http://dx.doi.org/10.1186/1479-5876-11-93] [PMID: 23570606]
[57]
Sutin AR, Terracciano A, Deiana B, et al. High Neuroticism and low Conscientiousness are associated with interleukin-6. Psychol Med 2010; 40(9): 1485-93.
[http://dx.doi.org/10.1017/S0033291709992029] [PMID: 19995479]
[58]
Yadav RK, Sarvottam K, Magan D, Yadav R. A two-year follow-up case of chronic fatigue syndrome: substantial improvement in personality following a yoga-based lifestyle intervention. J Altern Complement Med 2015; 21(4): 246-9.
[http://dx.doi.org/10.1089/acm.2014.0055] [PMID: 25825998]
[59]
Deuskar M. Stress reduction through yoga Nidra. Proceedings “Yoga – the Light of Microuniverse” of the International Interdisciplinary Scientific Conference “Yoga in Science – Future and Perspectives”. September 23-24; Belgrade, Serbia. 2010; pp. 72-80.
[60]
Paul A, Khan ML, Arunachalam A, Arunachalam K. Biodiversity and conservation of rhododendrons in Arunachal Pradesh in Indo-Burman biodiversity hotspot. Curr Sci 2005; 89: 623-34.
[61]
Saxena M, Saxena J, Neema R, Singh D, Gupta A. Phytochemistry of medicinal plants. J Pharmacogn Phytochem 2013; 6: 168-82.
[62]
Thaipong K, Boonprakob U, Crosby K, Cisneros-Zevallos L, Hawkins Byrne D. Comparison of ABTS, DPPH, FRAP, and ORAC assays for estimating antioxidant activity from guava fruit extracts. J Food Compos Anal 2006; 19(6-7): 669-75.
[http://dx.doi.org/10.1016/j.jfca.2006.01.003]
[63]
Seth SD, Sharma B. Medicinal plants in India. Indian J Med Res 2004; 120(1): 9-11.
[PMID: 15299226]
[64]
Roy Chengappa KN, Gannon JM, Forrest PE. Subtle changes in thyroid indices during a placebo-controlled study of an extract of Withania somnifera in persons with bipolar disorder. J Ayurveda Integr Med 2014; 5(4): 241-5.
[http://dx.doi.org/10.4103/0975-9476.146566] [PMID: 25624699]
[65]
Kaur G, Kulkarni SK. S.K. Kulkarni and G. Kaur, Comparative study of Antidepressants and Herbal Psychotropic drugs in a mouse model of chronic fatigue syndrome. J Chronic Fatigue Syndr 2000; 6(2): 23-35.
[http://dx.doi.org/10.1300/J092v06n02_04]
[66]
Abbas SS, Singh N. Anti-stress Agents (Herbs) of Indian Origin–Herbal Drugs, A Twenty First Century Perspective Institute of Nuclear Medicine and Allied Sciences, Defence Research and Development Organization(DRDO). Delhi: Government of India 2006; pp. 578-91.
[67]
Bhattacharya SK, Muruganandam AV. Adaptogenic activity of Withania somnifera: an experimental study using a rat model of chronic stress. Pharmacol Biochem Behav 2003; 75(3): 547-55.
[http://dx.doi.org/10.1016/S0091-3057(03)00110-2] [PMID: 12895672]
[68]
Rice-Evans C. Implications of the mechanisms of action of tea polyphenols as antioxidants in vitro for chemoprevention in humans. Proc Soc Exp Biol Med 1999; 220(4): 262-6.
[http://dx.doi.org/10.1046/j.1525-1373.1999.d01-45.x] [PMID: 10202400]
[69]
Feng Q, Torii Y, Uchida K, Nakamura Y, Hara Y, Osawa T. Black tea polyphenols, theaflavins, prevent cellular DNA damage by inhibiting oxidative stress and suppressing cytochrome P450 1A1 in cell cultures. J Agric Food Chem 2002; 50(1): 213-20.
[http://dx.doi.org/10.1021/jf010875c] [PMID: 11754570]
[70]
Ishikawa T, Suzukawa M, Ito T, et al. Effect of tea flavonoid supplementation on the susceptibility of low-density lipoprotein to oxidative modification. Am J Clin Nutr 1997; 66(2): 261-6.
[http://dx.doi.org/10.1093/ajcn/66.2.261] [PMID: 9250103]
[71]
Klaunig JE, Xu Y, Han C, et al. The effect of tea consumption on oxidative stress in smokers and nonsmokers. Proc Soc Exp Biol Med 1999; 220(4): 249-54.
[http://dx.doi.org/10.1046/j.1525-1373.1999.d01-43.x] [PMID: 10202398]
[72]
Pearson DA, Frankel ENR. Aeschbach andJ.B. German, Inhibitionof endothelial cell mediated low-density lipoprotein oxidationby green tea extracts. J Agric Food Chem 1998; 46: 1445-9.
[http://dx.doi.org/10.1021/jf970889b]
[73]
Y.L.Lin andJ.K. Lin, (-)-Epigallocatechin-3-gallate blocks the induction of nitric oxide synthase by down-regulating lipopolysaccharide-induced activity of transcription factor nuclear factor-_B. Mol Pharmacol 1997; 52: 465-72.
[http://dx.doi.org/10.1124/mol.52.3.465] [PMID: 9281609]
[74]
Sueoka N, Suganuma M, Sueoka E, et al. A new function of green tea: prevention of lifestyle-related diseases. Ann N Y Acad Sci 2001; 928(1): 274-80.
[http://dx.doi.org/10.1111/j.1749-6632.2001.tb05656.x] [PMID: 11795518]
[75]
Sachdeva AK, Kuhad A. V. Tiwari andK. Chopra, Epigallocatechin gallate ameliorates Chronic fatigue syndrome in mice: Behavioural and biochemical evidence. Behav Brain Res 2009; 205: 414-20.
[http://dx.doi.org/10.1016/j.bbr.2009.07.020] [PMID: 19643148]
[76]
Goyal RK, Singh J, Lal H. Asparagus racemosus--an update. Indian J Med Sci 2003; 57(9): 408-14.
[PMID: 14515032]
[77]
Hayes PY, Jahidin AH, Lehman R, Penman KW. Kitching andJ.J. De Voss, Structural revision of shatavarins I and IV, the major components from the roots of A. racemosus. Tetrahedron Lett 2006; 47: 6965-9.
[http://dx.doi.org/10.1016/j.tetlet.2006.07.121]
[78]
Velavan S, Nagulendran K, Mahesh R, Hazeena Begum V. In vitroantioxidant activity of Asparagus racemosus root. Pharmacogn Mag 2007; 3: 26.
[79]
Rege NN, Thatte UM, Dahanukar SA. Adaptogenic properties of six rasayana herbs used in Ayurvedic medicine. Phytother Res 1999; 13(4): 275-91.
[http://dx.doi.org/10.1002/(SICI)1099-1573(199906)13:4<275:AID-PTR510>3.0.CO;2-S] [PMID: 10404532]
[80]
Francis G, Kerem ZHPS. Makkar andK. Becker, The biological action of saponins in animal system: A review. Br J Nutr 2002; 88: 587-605.
[http://dx.doi.org/10.1079/BJN2002725] [PMID: 12493081]
[81]
Joshi T, Sah SP, Singh A. Antistress activity of ethanolic extract of Asparagus racemosus Willd roots in mice. Indian J Exp Biol 2012; 50(6): 419-24.
[PMID: 22734253]
[82]
Lestari MLAD, Indrayanto G. Curcumin. Profiles Drug Subst Excip Relat Methodol 2014; 39: 113-204.
[http://dx.doi.org/10.1016/B978-0-12-800173-8.00003-9] [PMID: 24794906]
[83]
Gupta SC, Patchva S, Aggarwal BB. Therapeutic roles of curcumin: Lessons learned from clinical trials. AAPS J 2013; 15(1): 195-218.
[http://dx.doi.org/10.1208/s12248-012-9432-8] [PMID: 23143785]
[84]
Aggarwal BB, Harikumar KB. Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases. Int J Biochem Cell Biol 2009; 41(1): 40-59.
[http://dx.doi.org/10.1016/j.biocel.2008.06.010] [PMID: 18662800]
[85]
Sahebkar A, Serban MC, Ursoniu S, Banach M. Effect of curcuminoids on oxidative stress: A systematic review and meta-analysis of randomized controlled trials. J Funct Foods 2015; 18: 898-909.
[http://dx.doi.org/10.1016/j.jff.2015.01.005]
[86]
Gupta A, Vij G, Sharma S, Tirkey N, Rishi P, Chopra K. Curcumin, a polyphenolic antioxidant, attenuates chronic fatigue syndrome in murine water immersion stress model. Immunobiology 2009; 214(1): 33-9.
[http://dx.doi.org/10.1016/j.imbio.2008.04.003] [PMID: 19159825]
[87]
Lopresti AL, Drummond PD. Efficacy of curcumin, and a saffron/curcumin combination for the treatment of major depression: A randomised, double-blind, placebo-controlled study. J Affect Disord 2017; 207: 188-96.
[http://dx.doi.org/10.1016/j.jad.2016.09.047] [PMID: 27723543]
[88]
Stojanović G, Dordevic A, Šmelcerović A. Do other Hypericum species have medical potential as St. John’s wort (Hypericum perforatum)? Curr Med Chem 2013; 20(18): 2273-95.
[http://dx.doi.org/10.2174/0929867311320180001] [PMID: 23521674]
[89]
Ng QX, Venkatanarayanan N, Ho CYX. Clinical use of Hypericum perforatum (St John’s wort) in depression: A meta-analysis. J Affect Disord 2017; 210: 211-21.
[http://dx.doi.org/10.1016/j.jad.2016.12.048] [PMID: 28064110]
[90]
Russo E, Scicchitano F, Whalley BJ, et al. Hypericum perforatum: pharmacokinetic, mechanism of action, tolerability, and clinical drug-drug interactions. Phytother Res 2014; 28(5): 643-55.
[http://dx.doi.org/10.1002/ptr.5050] [PMID: 23897801]
[91]
Valko M, Leibfritz D, Moncol J, Cronin MTD, Mazur M, Telser J. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 2007; 39(1): 44-84.
[http://dx.doi.org/10.1016/j.biocel.2006.07.001] [PMID: 16978905]
[92]
Singh A, Naidu PS, Gupta S, Kulkarni SK. Effect of natural and synthetic antioxidants in a mouse model of chronic fatigue syndrome. J Med Food 2002; 5(4): 211-20.
[http://dx.doi.org/10.1089/109662002763003366] [PMID: 12639396]
[93]
Zhang R, Ji Y, Zhang X, Kennelly EJ, Long C. Ethnopharmacology of Hypericum species in China: A comprehensive review on ethnobotany, phytochemistry and pharmacology. J Ethnopharmacol 2020; 254: 112686.
[http://dx.doi.org/10.1016/j.jep.2020.112686] [PMID: 32101776]
[94]
Garachh D, Patel A, Chakraborty M, Kamath JV. Phytochemical and pharmacological profile of Punica granatum: an overview. Int Res J Pharm 2012; 3: 65-8.
[95]
T. Devi andS. Das, Evaluation of protective effect of ethanolic extract of leaves of Punica granatum Linn. on forced swimming induced Chronic fatigue syndrome in mice. Int J Pharm Pharm Sci 2017; 9: 207-12.
[96]
Kaur S, Sharma N, Nehru B. Anti-inflammatory effects of Ginkgo biloba extract against trimethyltin-induced hippocampal neuronal injury. Inflammopharmacology 2018; 26(1): 87-104.
[http://dx.doi.org/10.1007/s10787-017-0396-2] [PMID: 28918573]
[97]
Hu H, Li Y, Xin Z, Zhang X. Ginkgolide B exerts anti-inflammatory and chondroprotective activity in LPS-induced chondrocytes. Adv Clin Exp Med 2018; 27(7): 913-20.
[http://dx.doi.org/10.17219/acem/70414] [PMID: 29905408]
[98]
Kan J, Chen L, Yeh A, Liu B, et al. A botanical product containing cistanche and Ginko extracts improve chronic fatigue syndrome: A randomized, double- blind, placebo controlled study. Res. Sq 2020; pp. 1-18.
[99]
Sharma PV. Darvyaguna Vijnan. (4th ed.). Varanasi: Chaukkhamba Sanskrit Sansthan 1978; pp. 763-76.
[100]
Srivastava RS. its Source and Active Principles. Proc 1998; 524.
[101]
Ghosal S. Chemistry of shilajit, an immunomodulatory Ayurvedic rasayan. Pure Appl Chem 1990; 62(7): 1285-8.
[http://dx.doi.org/10.1351/pac199062071285]
[102]
Agarwal SP, Khanna R, Karmarkar R, Anwer MK, Khar RK. Shilajit: a review. Phytother Res 2007; 21(5): 401-5.
[http://dx.doi.org/10.1002/ptr.2100] [PMID: 17295385]
[103]
A.K. Jaiswal andS.K. Bhattacharya, Effects of shilajit on memory, anxiety and brain monoamines in rats. Indian J Pharmacol 1992; 24: 12-7.
[104]
Surapaneni DK, Adapa SRSS, Preeti K, Teja GR, Veeraragavan M, Krishnamurthy S. Shilajit attenuates behavioral symptoms of chronic fatigue syndrome by modulating the hypothalamic–pituitary–adrenal axis and mitochondrial bioenergetics in rats. J Ethnopharmacol 2012; 143(1): 91-9.
[http://dx.doi.org/10.1016/j.jep.2012.06.002] [PMID: 22771318]
[105]
Moon K, Khadabadi SS, Deokate UA, Deore SL. Caesalpinia bonducella Overview. Rep Opinion 2010; 2: 83-90.
[106]
Shukla S, Mehta A, John J, Singh SP. Mehta andS.P. Vyas, Antioxidant activityand total phenolic content of ethanolic extract of Caesalpinia bonducella seeds. Food Chem Toxicol 2009; 47: 1848-51.
[http://dx.doi.org/10.1016/j.fct.2009.04.040] [PMID: 19422871]
[107]
Sachan NK, Verma S, Sachan AK, Hussain A. An investigation to antioxidant activity of Caesalpinia bonducella seeds. Ann Pharm Pharm Sci 2010; 1: 88-91.
[108]
Sarma P, Borah M, Das S. Evaluation of the protective effect of ethanolic extract of seed kernel of Caesalpinia bonducella Flem (EECB) on forced swimming-induced chronic fatigue syndrome in mice. Pharmacognosy Res 2019; 11(3): 254-9.
[http://dx.doi.org/10.4103/pr.pr_172_18]
[109]
Sathyapalan T, Beckett S, Rigby AS, Mellor DD, Atkin SL. High cocoa polyphenol rich chocolate may reduce the burden of the symptoms in chronic fatigue syndrome. Nutr J 2010; 9(1): 55.
[http://dx.doi.org/10.1186/1475-2891-9-55] [PMID: 21092175]
[110]
Peters JC. Tryptophan nutrition and metabolism: an overview. Adv Exp Med Biol 1991; 294: 345-58.
[http://dx.doi.org/10.1007/978-1-4684-5952-4_32] [PMID: 1772073]
[111]
Hooper L, Kay C, Abdelhamid A, et al. Effects of chocolate, cocoa, and flavan-3-ols on cardiovascular health: A systematic review and meta-analysis of randomized trials. Am J Clin Nutr 2012; 95(3): 740-51.
[http://dx.doi.org/10.3945/ajcn.111.023457] [PMID: 22301923]
[112]
Coe S, Axelsson E, Murphy V, et al. Flavonoid rich dark cocoa may improve fatigue in people with multiple sclerosis, yet has no effect on glycaemic response: An exploratory trial. Clin Nutr ESPEN 2017; 21: 20-5.
[http://dx.doi.org/10.1016/j.clnesp.2017.07.002] [PMID: 30014865]
[113]
Joshi GC, Tewari LM, Lohani N, Upreti K, Jalal JS, Tewari G. Diversity of orchids in Uttarakhand and their conservation strategy with special reference to their medicinal importance. Rep Opinion 2009; 1: 47-52.
[114]
Gutierrez RMP. Orchids: a review of uses in traditional medicine, its phytochemistry and pharmacology. J Med Plants Res 2010; 4: 592-638.
[115]
Majumder PL, Banerjee S, Maiti DC, Sen S. Stilbenoids from the orchids Agrostophyllum callosum and Coelogyne flaccida. Phytochemistry 1995; 39(3): 649-53.
[http://dx.doi.org/10.1016/0031-9422(95)00942-Z]
[116]
Majumder PL, Sen S, Majumder S. Phenanthrene derivatives from the orchid Coelogyne cristata. Phytochemistry 2001; 58(4): 581-6.
[http://dx.doi.org/10.1016/S0031-9422(01)00287-4] [PMID: 11576602]
[117]
Chakrabarty M, Datta GK, Ghosh S, Debnath PK. Induction of antioxidative enzyme by the ayurvedic herb Desmotrichum fimbriatum Bl. in mice. Indian J Exp Biol 2001; 39(5): 485-6.
[PMID: 11510136]
[118]
Kovács A, Vasas A, Hohmann J. Natural phenanthrenes and their biological activity. Phytochemistry 2008; 69(5): 1084-110.
[http://dx.doi.org/10.1016/j.phytochem.2007.12.005] [PMID: 18243254]
[119]
Mitra A, Kumar ST, Sachhidananda U, Dipankar B, Jayram H. Effect of Swarna jibanti (Coelogyne cristata) in alleviation of Chronic fatigue syndrome in aged wistar rats. J Ayurveda Integr Med 2017; 30: 1-6.
[120]
Fleming T. PDR for Herbal Medicines. Montvale, New Jersey: Medical Economics Company 2000.
[121]
Joshi H, Parle M. Nardostachys jatamansi improves learning and memory in mice. J Med Food 2006; 9(1): 113-8.
[http://dx.doi.org/10.1089/jmf.2006.9.113] [PMID: 16579738]
[122]
Sahu R, Dhongade HJ, Pandey A, et al. Medicinal properties of Nardostachys jatamansi: A review. Orient J Chem 2016; 32(2): 859-66.
[http://dx.doi.org/10.13005/ojc/320211]
[123]
Lyle N, Gomes A, Sur T, et al. The role of antioxidant properties of Nardostachys jatamansi in alleviation of the symptoms of the chronic fatigue syndrome. Behav Brain Res 2009; 202(2): 285-90.
[http://dx.doi.org/10.1016/j.bbr.2009.04.005] [PMID: 19375459]
[124]
Pushpangadan P, Rajasekharan S, Ratheshkumar PK, et al. ‘Arogyappacha’ (Trichopus zeylanicus gaerin), the ‘ginseng’ of kani tribes of agashyar hills (kerala) for ever green healh and vitality. Anc Sci Life 1988; 8(1): 13-6.
[PMID: 22557622]
[125]
Singh B, Gupta DK, Chandan BK. Adaptogenic activity of a glyco-peptido-lipid fraction from the alcoholic extract of Trichopus zeylanicus Gaertn. Phytomedicine 2001; 8(4): 283-91.
[http://dx.doi.org/10.1078/0944-7113-00038] [PMID: 11515718]
[126]
Biju VC. Therapeutic properties of Trichopus zeylanicus subsp. travancoricus, a rare Endangered Medicinal plant in South India: A review. iMedPub 2019; 5: 2.
[127]
Singh AE. Saxena andK.K. Bhutani, Adrenocorticosterone alteration in male, Albino mice treated with Trichopus zeylanicus, Withania Somnifera and Panax ginseng preprations. Phytother Res 2000; 14: 122-5.
[http://dx.doi.org/10.1002/(SICI)1099-1573(200003)14:2<122:AID-PTR529>3.0.CO;2-S] [PMID: 10685111]
[128]
Rishikesh BRS. Kumar andP. Perumal, Anxiolytic activity and antidepressant activity of saponin fraction of Trichopus zeylanicus gaertn, in mice. Int J Phytopharm 2012; 3: 1-6.
[129]
Singh B, Chandan BK, Sharma N, Singh S, Khajuria A, Gupta DK. Adaptogenic activity of glyco-peptido-lipid fraction from the alcoholic extract of Trichopus zeylanicus Gaerten (part II). Phytomedicine 2005; 12(6-7): 468-81.
[http://dx.doi.org/10.1016/j.phymed.2005.01.009] [PMID: 16008124]
[130]
Evans DA, Subramoniam AS. Rajasekharan andP. Pushpangadan, Effect of Trichopus zeylanicus leaf extract on energy metabolism in mice during exercise and at rest. Indian J Pharmacol 2002; 34: 32-7.
[131]
Tharakan BM. Dhanasekaran andB.V. Manyam, Antioxidant and DNA protecting properties of anti-fatigue herb Trichopus zeylanicus. Phytother Res 2005; 8: 19669-73.
[132]
Dorman HJD, Bachmayer O, Kosar M, Hiltunen R. Antioxidant properties of aqueous extracts from selected lamiaceae species grown in Turkey. J Agric Food Chem 2004; 52(4): 762-70.
[http://dx.doi.org/10.1021/jf034908v] [PMID: 14969528]
[133]
Q. Nizami andM.A. Jafri, Unani drug, Jadwar (Delphinium denudatum Wall.)—a review. Indian J Tradit Knowl 2006; 5: 463-7.
[134]
S. Mohanapriya andG. Vijaiyansiva, Bioactive constituent of Delphinium denudatum Wall. and their antioxidant efficacy. J Acad Ind Res 2013; 2: 138-41.
[135]
Abid M, Gosh AK, Ali Khan N. In vivo Psychopharmacological Investigation of Delphinium Denudatum and Amaranthus Spinosus Extracts on Wistar Rats. Basic Clin Neurosci 2017; 8(6): 503-12.
[http://dx.doi.org/10.29252/nirp.bcn.8.6.503] [PMID: 29942433]
[136]
Zaheer I, Rahman SZ, Khan RA, Parveen M, Ahmad M. Evaluation of Analgesic Activity of Extracts of Delphinium denudatum in Animal Models: A Dose-dependent Pre-clinical Trial. J Clin Diagn Res 2018; 12: 12.
[http://dx.doi.org/10.7860/JCDR/2018/37415.12322]
[137]
Hu QL, Zhang LJ, Li YNYJ. Ding andF.L. Li. Purification and anti-fatigue activity of flavonoids from corn silk. Int J Phys Sci 2010; 5: 321-6.
[138]
Su KY, Yu CY, Chen YW, et al. Rutin, a flavonoid and principal component of saussurea involucrata, attenuates physical fatigue in a forced swimming mouse model. Int J Med Sci 2014; 11(5): 528-37.
[http://dx.doi.org/10.7150/ijms.8220] [PMID: 24693223]
[139]
Puri BK. Long-chain polyunsaturated fatty acids and the pathophysiology of myalgic encephalomyelitis (chronic fatigue syndrome). J Clin Pathol 2006; 60(2): 122-4.
[http://dx.doi.org/10.1136/jcp.2006.042424] [PMID: 16935966]
[140]
Ruxton CHS, Reed SC, Simpson MJA, Millington KJ. The health benefits of omega-3 polyunsaturated fatty acids: A review of the evidence. J Hum Nutr Diet 2004; 17(5): 449-59.
[http://dx.doi.org/10.1111/j.1365-277X.2004.00552.x] [PMID: 15357699]
[141]
Daneshfard B, Yekta NH, Khoshdel A, Heiran A, Cheraghi R, Yarmohammadi H. The effect of Delphinium denudatum (Jadwar) on fatigue: A randomized double blind placebo-controlled clinical trial. Complement Ther Med 2019; 46: 29-35.
[http://dx.doi.org/10.1016/j.ctim.2019.05.027] [PMID: 31519284]
[142]
Gupta RK. Medicinal and aromatic plants. 1st edition. CBS publishers & distributors 2010; p. 116-7.
[143]
Gupta AKN, Tondonand M. Sharma, Quality Standards of Indian Medicinal Plants, medicinal plants unit. Published by Indian Council of Medical Research 2008; 2: 47-53.
[144]
Kirtikar KR, Basu BD. Indian Medicinal Plants. International book distributors 2006; 2: 856-60.
[145]
Nadkarni KM. Indian Materia Medica. Popular Prakashan, Bombay 2009; 1: 285-6.
[146]
Nyeem MA, Haque MS, Hoque MA. M.M. Islam andS. Islam, Cassia fistula Linn: phytochemical and pharmacological studies: A review. Int J Adv Sci Res 2017; 2: 25-30.
[147]
Khare CP. Indian medicinal plants. Springer 2007; p. 128.
[http://dx.doi.org/10.1007/978-0-387-70638-2]
[148]
Agarwal SS, Paridhavi M. Clinically useful herbal drugs. Ahuja publishing house 2005; pp. 281-2.
[149]
Rastogi RP, Mehrotra BN. Compendium of Indian Medicinal plants. Central Drug ResearchInstitute. Lucknow and National Institute of Science Communication and Information Resources, New Delhi 2004; 3: 140.
[150]
Siddhuraju P, Mohan PS, Becker K. Studies on the antioxidant activity of Indian Laburnum (Cassia fistula L.): a preliminary assessment of crude extracts from stem bark, leaves, flowers and fruit pulp. Food Chem 2002; 79(1): 61-7.
[http://dx.doi.org/10.1016/S0308-8146(02)00179-6]
[151]
Mazumder UK, Gupta M, Rath N. CNS activities of Cassia fistula in mice. Phytother Res 1998; 12(7): 520-2.
[http://dx.doi.org/10.1002/(SICI)1099-1573(199811)12:7<520:AID-PTR345>3.0.CO;2-O]
[152]
Sarma P, Borah M, Das S. Evaluation of the effect of ethanolic extract of fruit pulp of Cassia fistula Linn. on forced swimming induced chronic fatigue syndrome in mice. Res Pharm Sci 2015; 10(3): 206-13.
[PMID: 26600847]
[153]
Singh V, Amdekar S, Verma O. Ocimum sanctum (tulsi): Biopharmacological activities. WebmedCentral Pharmacol 2010; 1(10): WMC001046.
[154]
Warrier PK, Nambiar VPK, Ramankutty C. A compendium of 500 species. Indian medicinal plants Orient longman publisher 1995.
[155]
Satyavati GV, Gupta AK, Tandon N. Ocimum sanctum linn. Medicinal plants of India. ICMR, India 1987; 2: 355-71.
[156]
Mediratta PK, Sharma KK, Singh S. Evaluation of immunomodulatory potential of Ocimum sanctum seed oil and its possible mechanism of action. J Ethnopharmacol 2002; 80(1): 15-20.
[http://dx.doi.org/10.1016/S0378-8741(01)00373-7] [PMID: 11891082]
[157]
Anbarasu K, Vijayalakshmi G. Improved shelf life of protein-rich tofu using Ocimum sanctum (tulsi) extracts to benefit Indian rural population. J Food Sci 2007; 72(8): M300-5.
[http://dx.doi.org/10.1111/j.1750-3841.2007.00487.x] [PMID: 17995609]
[158]
Gupta P, Yadav DK, Siripurapu KB, Palit G, Maurya R. Constituents of Ocimum sanctum with antistress activity. J Nat Prod 2007; 70(9): 1410-6.
[http://dx.doi.org/10.1021/np0700164] [PMID: 17850106]
[159]
Joshi H, Parle M. Evaluation of nootropic potential of Ocimum sanctum Linn. in mice. Indian J Exp Biol 2006; 44(2): 133-6.
[PMID: 16480180]
[160]
Mishra P, Mishra S. Study of antibacterial activity of Ocimum sanctum extract against gram positive and gramnegative bacteria. Am J Food Technol 2011; 6: 336-41.
[http://dx.doi.org/10.3923/ajft.2011.336.341]
[161]
Hemalatha R, Babu KN, Karthik M, Ramesh R, Kumar BD, Kumar PU. Immunomodulatory activity and Th1/Th2 cytokine response of Ocimum sanctum in myelosuppressed swiss albino mice. Trends in Medical Research 2011; 6(1): 23-31.
[http://dx.doi.org/10.3923/tmr.2011.23.31]
[162]
Biswas NP, Biswas AK. Evaluation of some leaf dusts as grain protectant against rice weevil Sitophilus oryzae (Linn.). Environ Ecol 2005; 23: 485-8.
[163]
Pandey G, Madhuri S. Pharmacological activities of Ocimum sanctum (tulsi): a review. Int J Pharm Sci Rev Res 2010; 5: 61-6.
[164]
Gupta SK, Prakash J, Srivastava S. Validation of traditional claim of Tulsi, Ocimum sanctum Linn. as a medicinal plant. Indian J Exp Biol 2002; 40(7): 765-73.
[PMID: 12597545]
[165]
Singh N, Verma P, Mishra N, Nath R. A comparative evaluation of some anti-stress agents of plant origin. Indian J Pharmacol 1991; 23: 99-103.
[166]
Kelm MA, Nair MG, Strasburg GM, DeWitt DL. Antioxidant and cyclooxygenase inhibitory phenolic compounds from Ocimum sanctum Linn. Phytomedicine 2000; 7(1): 7-13.
[http://dx.doi.org/10.1016/S0944-7113(00)80015-X] [PMID: 10782484]
[167]
Venu Prasa MP, Khanum F. Antifatigue activity of ethanolic extract of Ocimum sanctum in rats. Res J Med Plant 2012; 6(1): 37-46.
[http://dx.doi.org/10.3923/rjmp.2012.37.46]

Rights & Permissions Print Cite
Article Metrics
17
2
Wayfinder Image
© 2024 Bentham Science Publishers | Privacy Policy